Contact
searchSearch
HMP Global

Advertisement

Advertisement

ADVERTISEMENT

Seizures Topic Center

Pop quiz.
Quiz
Is topiramate a safe alternative to valporate when prescribing antiseizure medication to pregnant women?
06/09/2022
Take the quiz now to test your knowledge!
Take the quiz now to test your knowledge!
Take the quiz now to test your...
06/09/2022
Neurology
News
Prenatal Exposure to Antiseizure Medications May Increase Risk of Autism and Intellectual Disability
06/07/2022
Brionna Mendoza
Prenatal exposure to antiseizure medications, frequently prescribed to pregnant women with epilepsy, increase a child’s risk of neurodevelopmental disorder.
Prenatal exposure to antiseizure medications, frequently prescribed to pregnant women with epilepsy, increase a child’s risk of neurodevelopmental disorder.
Prenatal exposure to antiseizure...
06/07/2022
Neurology
News
Telemedicine Diagnoses for Neurological Patients Effective, but Room to Improve
05/16/2022
Brionna Mendoza
Teleneurological consultations overall produce accurate diagnoses in emergency situations for both stroke and nonstroke patients, but accuracy varies based on the specific diagnosis and disease case.
Teleneurological consultations overall produce accurate diagnoses in emergency situations for both stroke and nonstroke patients, but accuracy varies based on the specific diagnosis and disease case.
Teleneurological consultations...
05/16/2022
Neurology
Quiz: What amount of patients with epilepsy have common epilepsies versus rare epilepsies?
02/04/2022
Focal epilepsy and idiopathic generalized epilepsy, also known as common epilepsies, comprise approximately _____ of all patient cases.
Focal epilepsy and idiopathic generalized epilepsy, also known as common epilepsies, comprise approximately _____ of all patient cases.
Focal epilepsy and idiopathic...
02/04/2022
Neurology
Conference Coverage
Treatments Needed for Rare Epilepsy Disorders
07/16/2021
Jacqueline A. French discussed the latest research in the field of epilepsy and seizure disorders during a presentation at Neurology Week.
Jacqueline A. French discussed the latest research in the field of epilepsy and seizure disorders during a presentation at Neurology Week.
Jacqueline A. French discussed...
07/16/2021
Neurology
Quiz: Is Status Epilepticus (SE) Associated With a Large Financial and Physical Burden on Patients?
05/27/2021
True or False: Status epilepticus (SE) continues to be associated with a large financial and physical burden on patients.
True or False: Status epilepticus (SE) continues to be associated with a large financial and physical burden on patients.
True or False: Status...
05/27/2021
Neurology
News
Mortality Rate and Hospitalization Costs Rise with Refractoriness of Status Epilepticus
05/13/2021
Status epilepticus continues to be associated with a larger burden on patients financially and physically, with high mortality rates and hospitalization costs that increase with disease refractoriness, according to a new analysis.
Status epilepticus continues to be associated with a larger burden on patients financially and physically, with high mortality rates and hospitalization costs that increase with disease refractoriness, according to a new analysis.
Status epilepticus continues to...
05/13/2021
Neurology
News
FDA Clears Wearable EEG Device System
01/06/2021
The new device, which was given 510(k) clearance from the US Food and Drug Administration, allows for the remote diagnosis, monitoring, and assessment of epilepsy.
The new device, which was given 510(k) clearance from the US Food and Drug Administration, allows for the remote diagnosis, monitoring, and assessment of epilepsy.
The new device, which was given...
01/06/2021
Neurology
Pop Quiz: Risk Factors for Seizure Recurrence
Quiz
Pop Quiz: Risk Factors for Seizure Recurrence
01/05/2021
According to the American Academy of Neurology 2015 guideline for the management of an unprovoked first seizure among adults, what are the risk factors for seizure recurrence? Test your knowledge in our pop quiz.
According to the American Academy of Neurology 2015 guideline for the management of an unprovoked first seizure among adults, what are the risk factors for seizure recurrence? Test your knowledge in our pop quiz.
According to the American...
01/05/2021
Neurology
News
SUDEP Significantly More Common Among Infants, Children Than Previously Thought
12/04/2020
In a new study presented at the American Epilepsy Society virtual meeting, AES2020, researchers identified specific age groups that were most at risk for sudden unexpected death in epilepsy in a registry of patients aged 0 to 17 years.
In a new study presented at the American Epilepsy Society virtual meeting, AES2020, researchers identified specific age groups that were most at risk for sudden unexpected death in epilepsy in a registry of patients aged 0 to 17 years.
In a new study presented at the...
12/04/2020
Neurology

Advertisement

Advertisement

News

Sleep Disorders Linked With Epilepsy in Older Adults
News
Sleep Disorders Linked With Epilepsy in Older Adults
05/07/2024
Jolynn Tumolo
Sleep apnea and low oxygen levels during sleep are associated with late-onset epilepsy independently of hypertension and stroke, according to a study published online in the journal Sleep.
Sleep apnea and low oxygen levels during sleep are associated with late-onset epilepsy independently of hypertension and stroke, according to a study published online in the journal Sleep.
Sleep apnea and low oxygen...
05/07/2024
Neurology
Prenatal Exposure to Antiseizure Medications May Not Increase Risk of Epilepsy in Children
News
Prenatal Exposure to Antiseizure Medications May Not Increase Risk of Epilepsy in Children
03/05/2024
Evi Arthur
No association was found between exposure to antiseizure medications (ASMs), including valproate, during pregnancy and children developing epilepsy, in a recent prospective, population-based register cohort study results published in JAMA...
No association was found between exposure to antiseizure medications (ASMs), including valproate, during pregnancy and children developing epilepsy, in a recent prospective, population-based register cohort study results published in JAMA...
No association was found between...
03/05/2024
Neurology
Odds of Epilepsy with Moderate Traumatic Brain Injury Higher in Nondeployed Veterans
News
Odds of Epilepsy With Moderate Traumatic Brain Injury Higher in Nondeployed Veterans
12/18/2023
Jolynn Tumolo
The risk of epilepsy in post-9/11 US veterans with moderate or severe traumatic brain injury (TBI) is higher in those who were not deployed compared with those who were deployed, according to study findings published online ahead of print...
The risk of epilepsy in post-9/11 US veterans with moderate or severe traumatic brain injury (TBI) is higher in those who were not deployed compared with those who were deployed, according to study findings published online ahead of print...
The risk of epilepsy in...
12/18/2023
Neurology
Cerebellum Identified as Source of Generalized Convulsive Seizures
News
Cerebellum Identified as Source of Generalized Convulsive Seizures
08/21/2023
Jolynn Tumolo
The cerebellum contributes to generalized convulsive seizures by altering the activity of a specific group of neurons in the midbrain that subsequently initiates the seizures, new study results suggest.
The cerebellum contributes to generalized convulsive seizures by altering the activity of a specific group of neurons in the midbrain that subsequently initiates the seizures, new study results suggest.
The cerebellum contributes to...
08/21/2023
Neurology
No Difference in Neurodevelopmental Outcomes With Fetal Antiseizure Drug Exposure
News
No Difference in Neurodevelopmental Outcomes With Fetal Antiseizure Drug Exposure
08/14/2023
Jolynn Tumolo
Neurodevelopmental outcomes did not differ between 3-year-olds who were exposed to antiseizure medications in utero and their peers who were not exposed, according to a study published in The Lancet Neurology.
Neurodevelopmental outcomes did not differ between 3-year-olds who were exposed to antiseizure medications in utero and their peers who were not exposed, according to a study published in The Lancet Neurology.
Neurodevelopmental outcomes did...
08/14/2023
Neurology
News
For Pediatric Drug-Resistant Epilepsy, Modified Atkins May Be Best Dietary Intervention
02/07/2023
Jolynn Tumolo
Although the ketogenic diet, modified Atkins diet, and low glycemic index therapy were each more effective than care as usual for short-term seizure reduction in childhood drug-resistant epilepsy, the modified Atkins diet may be the most...
Although the ketogenic diet, modified Atkins diet, and low glycemic index therapy were each more effective than care as usual for short-term seizure reduction in childhood drug-resistant epilepsy, the modified Atkins diet may be the most...
Although the ketogenic diet,...
02/07/2023
Neurology
News
Modified Atkins Diet Plus Medication Reduces Seizures in Drug-Resistant Epilepsy
01/09/2023
Jolynn Tumolo
Combining a modified Atkins diet with medication reduced seizures and improved quality of life in adolescents and adults with drug-resistant epilepsy, according to findings from a randomized controlled trial published in Neurology.
Combining a modified Atkins diet with medication reduced seizures and improved quality of life in adolescents and adults with drug-resistant epilepsy, according to findings from a randomized controlled trial published in Neurology.
Combining a modified Atkins diet...
01/09/2023
Neurology
News
Bidirectional, Long-term Relationship Found Between Epilepsy and Depression
12/13/2022
Jolynn Tumolo
The bidirectional association between depression and epilepsy is a long-term relationship, according to a large-scale cohort study published in the journal Neurology.
The bidirectional association between depression and epilepsy is a long-term relationship, according to a large-scale cohort study published in the journal Neurology.
The bidirectional association...
12/13/2022
Neurology
News
Prenatal Exposure to Antiseizure Medications May Increase Risk of Autism and Intellectual Disability
06/07/2022
Brionna Mendoza
Prenatal exposure to antiseizure medications, frequently prescribed to pregnant women with epilepsy, increase a child’s risk of neurodevelopmental disorder.
Prenatal exposure to antiseizure medications, frequently prescribed to pregnant women with epilepsy, increase a child’s risk of neurodevelopmental disorder.
Prenatal exposure to antiseizure...
06/07/2022
Neurology
News
Telemedicine Diagnoses for Neurological Patients Effective, but Room to Improve
05/16/2022
Brionna Mendoza
Teleneurological consultations overall produce accurate diagnoses in emergency situations for both stroke and nonstroke patients, but accuracy varies based on the specific diagnosis and disease case.
Teleneurological consultations overall produce accurate diagnoses in emergency situations for both stroke and nonstroke patients, but accuracy varies based on the specific diagnosis and disease case.
Teleneurological consultations...
05/16/2022
Neurology
Fremanezumab Shows Positive Results for Pediatric Use in Phase 3 Trial
News
Fremanezumab Shows Positive Results for Pediatric Use in Phase 3 Trial
08/08/2024
In July, Teva announced positive results in a phase 3 trial of migraine medication Ajovy (fremanezumab) for children and adolescents, making it the first anti-CGRP (calcitonin gene-related peptide) monoclonal antibody to be effective in this...
In July, Teva announced positive results in a phase 3 trial of migraine medication Ajovy (fremanezumab) for children and adolescents, making it the first anti-CGRP (calcitonin gene-related peptide) monoclonal antibody to be effective in this...
In July, Teva announced positive...
08/08/2024
Neurology
brain waves
News
High-Dose Statins May Not Benefit Patients With Mild Ischemic Stroke
08/08/2024
Compared with moderate-dose therapy, high-dose statin therapy in patients with mild ischemic stroke did not decrease the risk of stroke recurrence and was associated with an increased risk of intracranial hemorrhage over 12 months.
Compared with moderate-dose therapy, high-dose statin therapy in patients with mild ischemic stroke did not decrease the risk of stroke recurrence and was associated with an increased risk of intracranial hemorrhage over 12 months.
Compared with moderate-dose...
08/08/2024
Neurology
An illustration of a healthcare provider conducting a telehealth appointment
News
Teleneurology Visits Acceptable to Patients Across Neurologic Conditions
08/05/2024
Regardless of their neurologic condition, patients rated outpatient teleneurology appointments as highly acceptable, according to a study published in the Journal of Neurology.
Regardless of their neurologic condition, patients rated outpatient teleneurology appointments as highly acceptable, according to a study published in the Journal of Neurology.
Regardless of their neurologic...
08/05/2024
Neurology
The US Food and Drug Administration headquarters sign.
News
DMD Gene Therapy Indication Expanded to Include Boys 4 and Older
08/01/2024
The US FDA approved an indication expansion for the gene therapy Elevidys (delandistrogene moxeparvovec-rokl) to include patients with Duchenne muscular dystrophy (DMD) with a confirmed mutation in the DMD gene who are nonambulatory and 4...
The US FDA approved an indication expansion for the gene therapy Elevidys (delandistrogene moxeparvovec-rokl) to include patients with Duchenne muscular dystrophy (DMD) with a confirmed mutation in the DMD gene who are nonambulatory and 4...
The US FDA approved an...
08/01/2024
Neurology
A person walks down a boarded path with sunlight and trees in the background
News
Backward Walking Speed Reserve Reflects Disease Severity in Patients With MS
07/30/2024
Backward walking speed reserve, or the difference between an individual’s preferred and maximal backward walking speed, was associated with disease severity in patients with multiple sclerosis (MS).
Backward walking speed reserve, or the difference between an individual’s preferred and maximal backward walking speed, was associated with disease severity in patients with multiple sclerosis (MS).
Backward walking speed reserve,...
07/30/2024
Neurology
FDA Approves Efgartigimod Alfa/Hyaluronidase for CIDP Treatment
News
FDA Approves Efgartigimod Alfa/Hyaluronidase for CIDP Treatment
07/29/2024
VYVGART Hytrulo (efgartigimod alfa/hyaluronidase) was recently approved by the Food and Drug Administration (FDA) for the treatment of adults with chronic inflammatory demyelinating polyneuropathy (CIDP). 
VYVGART Hytrulo (efgartigimod alfa/hyaluronidase) was recently approved by the Food and Drug Administration (FDA) for the treatment of adults with chronic inflammatory demyelinating polyneuropathy (CIDP). 
VYVGART Hytrulo (efgartigimod...
07/29/2024
Neurology
A middle-aged male running
News
Moderate Physical Activity May Mitigate ALS Risk for Male Patients
07/25/2024
Male individuals who engage in moderate physical activity and fitness may lower their risk for amyotrophic lateral sclerosis (ALS) later in life, according to study findings published in Neurology.
Male individuals who engage in moderate physical activity and fitness may lower their risk for amyotrophic lateral sclerosis (ALS) later in life, according to study findings published in Neurology.
Male individuals who engage in...
07/25/2024
Neurology
Pitolisant Receives FDA Approval for Pediatric Patients With Narcolepsy
News
Pitolisant Receives FDA Approval for Pediatric Patients With Narcolepsy
07/23/2024
The US Food and Drug Administration (FDA) recently approved Wakix (pitolisant) for the treatment of excessive daytime sleepiness in pediatric patients 6 years and older with narcolepsy, US maker Harmony Biosciences announced.
The US Food and Drug Administration (FDA) recently approved Wakix (pitolisant) for the treatment of excessive daytime sleepiness in pediatric patients 6 years and older with narcolepsy, US maker Harmony Biosciences announced.
The US Food and Drug...
07/23/2024
Neurology
Chronic Loneliness Associated With Hiked Stroke Risk in Older Adults
News
Chronic Loneliness Associated With Hiked Stroke Risk in Older Adults
07/22/2024
Chronic loneliness was associated with higher stroke risk, independent of other factors, according to recent prospective cohort study results published in eClinicalMedicine. 
Chronic loneliness was associated with higher stroke risk, independent of other factors, according to recent prospective cohort study results published in eClinicalMedicine. 
Chronic loneliness was...
07/22/2024
Neurology
a hand breaks a wooden human figurine in half
News
Atogepant Reduces Migraine Days in Patients With Pain Medication Overuse
07/18/2024
The calcitonin gene-related peptide inhibitor atogepant reduced monthly migraine and headache days, as well as days using pain medication, in patients with chronic migraine with and without acute medication overuse.
The calcitonin gene-related peptide inhibitor atogepant reduced monthly migraine and headache days, as well as days using pain medication, in patients with chronic migraine with and without acute medication overuse.
The calcitonin gene-related...
07/18/2024
Neurology

Advertisement

Advertisement

Alzheimer's Disease CME Series

Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
11/19/2020
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources To view accreditation information/faculty disclosures for the program, click 
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources To view accreditation information/faculty disclosures for the program, click 
Early Alzheimer’s Disease:...
11/19/2020
Neurology
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
11/19/2020
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesOnline Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesOnline Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease:...
11/19/2020
Neurology
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
11/19/2020
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click...
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click...
Early Alzheimer’s Disease:...
11/19/2020
Neurology
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data
11/17/2020
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early...
11/17/2020
Neurology
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data
11/17/2020
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data Online Form - PBHLN-NLN Alzheimers Video Series
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data Online Form - PBHLN-NLN Alzheimers Video Series
Emerging Treatments for Early...
11/17/2020
Neurology
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data
11/17/2020
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety DataTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation...
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety DataTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation...
Emerging Treatments for Early...
11/17/2020
Neurology
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action
11/12/2020
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early...
11/12/2020
Neurology
Early Alzheimer’s Disease Overview: Burden of Disease, Quality-of-Life Impacts, and Pathophysiology
11/12/2020
Early Alzheimer’s Disease Overview: Burden of Disease, Quality-of-Life Impacts, and Pathophysiology Online Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease Overview: Burden of Disease, Quality-of-Life Impacts, and Pathophysiology Online Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease...
11/12/2020
Neurology
Claim-Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action
11/12/2020
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of ActionTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation button...
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of ActionTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation button...
Emerging Treatments for Early...
11/12/2020
Neurology
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease
11/10/2020
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease To view accreditation information/faculty disclosures for the program, click 
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease To view accreditation information/faculty disclosures for the program, click 
Current Treatment Limitations...
11/10/2020
Neurology

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use

Advertisement

Advertisement